Article
Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Mar 2017
Berden Floor A C, Aaldering Bryan R R Z, Groenewoud Hans, IntHout Joanna, Kievit Wietske, Drenth Joost P H
Abstract excerpt
BACKGROUND & AIMS: Direct-acting antivirals (DAAs) are effective in the treatment of chronic hepatitis C virus (HCV) infection, although results for patients infected with genotype 3 are suboptimal. There are several regimens available, however, direct comparisons have not been made and are unlikely to occur. We aimed to identify the most effective DAA regimen for patients infected with HCV genotype 3 and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.